Download PDF
physiopraxis 2025; 23(01): 42-45
DOI: 10.1055/a-2443-2775
Therapie

Hochkomplex und äußerst individuell – Physiotherapeutisches Screening bei Post und Long Covid

Jesko Streeck
› Further Information
Also available at
    Permissions and Reprints

Eine Infektion mit SARS-CoV-2 führt häufig zu neuen Symptomen oder persistierenden Beschwerden. In der Praxis ist es hilfreich, die Beschwerden klassifizieren zu können, ein Screening zu beherrschen und weitere diagnostische Kriterien zu kennen.



Publication History

Article published online:
21 January 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literaturverzeichnis

  • 1 Lippi G, Sanchis-Gomar F, Henry BM. COVID-19 and its long-term sequelae: what do we know in 2023?. Pol Arch Intern Med 2023; 133 (04) 16402
    CrossrefPubMedSearch in Google Scholar
  • 2 Chuang HJ, Lin CW, Hsiao MY. et al Long COVID and rehabilitation. J Formos Med Assoc 2024; 123 Suppl 1 S61-S69
    CrossrefPubMedSearch in Google Scholar
  • 3 Carruthers BM, van de Sande MI, De Meirleir KL. et al Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med 2011; 270 (04) 327-338
    CrossrefPubMedSearch in Google Scholar
  • 4 Jäkel B, Kedor C, Grabowski P. et al Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS. J Transl Med 2021; 19 (01) 159
    CrossrefPubMedSearch in Google Scholar
  • 5 Bateman L, Bested AC, Bonilla HF. et al Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management. Mayo Clin Proc 2021; 96 (11) 2861-2878
    CrossrefPubMedSearch in Google Scholar
  • 6 Elmer N, Reisshauer A, Liebl M. Stille Hypoxie nach COVID-19 – gefährliche Unbekannte für die Rehabilitation. Physikalische Medizin, Rehabilitationsmedizin, Kurortmedizin 2022; 32 (01) 08-10
    Thieme ConnectSearch in Google Scholar
  • 7 Devaux CA, Lagier JC. Unraveling the Underlying Molecular Mechanism of 'Silent Hypoxia' in COVID-19 Patients Suggests a Central Role for Angiotensin II Modulation of the AT1R-Hypoxia-Inducible Factor Signaling Pathway. J Clin Med 2023; 12 (06) 2445
    CrossrefPubMedSearch in Google Scholar
  • 8 Fanciulli A, Campese N, Wenning GK. The Schellong test: detecting orthostatic blood pressure and heart rate changes in German-speaking countries. Clin Auton Res 2019; 29 (04) 363-366
    CrossrefPubMedSearch in Google Scholar
  • 9 Vernino S, Bourne KM, Stiles LE. et al Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1. Auton Neurosci 2021; 235: 102828
    CrossrefPubMedSearch in Google Scholar
  • 10 Spahic JM, Hamrefors V, Johansson M. et al Malmö POTS symptom score: Assessing symptom burden in postural orthostatic tachycardia syndrome. J Intern Med 2023; 293 (01) 91-99
    CrossrefPubMedSearch in Google Scholar
  • 11 Hoitsma E, De Vries J, Drent M. The small fiber neuropathy screening list: Construction and cross-validation in sarcoidosis. Respir Med 2011; 105 (01) 95-100
    CrossrefPubMedSearch in Google Scholar
  • 12 Voortman M, Beekman E, Drent M. et al Determination of the smallest detectable change (SDC) and the minimal important difference (MID) for the Small Fiber Neuropathy Screening List (SFNSL) in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2018; 35 (04) 333-341
    CrossrefPubMedSearch in Google Scholar
  • 13 Tobin K, Giuliani MJ, Lacomis D. Comparison of different modalities for detection of small fiber neuropathy. Clin Neurophysiol 1999; 110 (11) 1909-1912
    CrossrefPubMedSearch in Google Scholar
  • 14 Cascio MA, Mukhdomi T. Small Fiber Neuropathy. 2022. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024
    Search in Google Scholar
  • 15 Grach SL, Seltzer J, Chon TY. et al Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Mayo Clin Proc 2023; 98 (10) 1544-1551
    CrossrefPubMedSearch in Google Scholar